Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)

Toshitaka Nakamura, Toshio Matsumoto, Toshitsugu Sugimoto, Takayuki Hosoi, Takami Miki, Itsuo Gorai, Hideki Yoshikawa, Yoshiya Tanaka, Sakae Tanaka, Teruki Sone, Tetsuo Nakano, Masako Ito, Shigeyuki Matsui, Toshiyuki Yoneda, Hideo Takami, Ko Watanabe, Taisuke Osakabe, Masataka Shiraki, Masao Fukunaga
  • The Journal of Clinical Endocrinology & Metabolism, July 2014, Endocrine Society
  • DOI: 10.1210/jc.2013-4175

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1210/jc.2013-4175

The following have contributed to this page: Dr. Sakae Tanaka